Cargando…
Immune Thrombocytopenia Purpura Relapse in Patients Who Received mRNA COVID-19 Vaccines
Autores principales: | Qasim, Hana, Rahhal, Alaa, Alshurafa, Awni, Alammora, Abdelkarim, Alsa'ed, Khaled, Alsayed, Ahmed, Faiyoumi, Baha, AbuAfifeh, Leen, Abu-Tineh, Mohammad, Yassin, Mohamed A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665281/ http://dx.doi.org/10.1182/blood-2022-159901 |
Ejemplares similares
-
Immune Thrombocytopenia Relapse in Patients Who Received mRNA COVID-19 Vaccines
por: Qasim, Hana, et al.
Publicado: (2023) -
A Challenging Case of a Patient With Immune Thrombocytopenic Purpura on Eltrombopag Who Developed Atrial Fibrillation: An Anticoagulation Dilemma
por: Yasin, Ahmed K, et al.
Publicado: (2023) -
Omicron-Induced Immune Thrombocytopenia: A Case Report
por: Toba, Haneen A, et al.
Publicado: (2023) -
Sickle cell leg ulcer successfully managed by hyperbaric oxygen: a case report
por: Alshurafa, Awni, et al.
Publicado: (2023) -
SARS-CoV-2 Omicron Variant in Patients With Chronic Myeloid Leukemia: A Retrospective Study
por: Ali, Elrazi A, et al.
Publicado: (2022)